Designing a Pre-IPO Overview Deck for a Clinical-Stage Biotech Company
Bloom BioSciences is developing an oral immunotherapy for cold tumors that respond poorly to existing treatments. Ahead of pre-IPO investor conversations, the company needed to bring its science, clinical evidence, market opportunity, and milestones into one clear story. We created a 25-slide company overview presentation that investors could understand, evaluate, and follow.
All the content and company name is redacted/replaced to maintain confidentiality.
Biotechnology
3-4 weeks
Company Overview
Miami, FL
The company’s story was spread across previous decks, working documents, clinical-data exports, scientific references, software screenshots, AI-generated layouts, and notes from different contributors. Each source contained an important part of the story. Together, they still did not give investors a clear path from the science to the investment opportunity.
Pain-Points
Important information lived across multiple files, formats, and working versions.
The science was credible but difficult for a broader investment audience to follow quickly.
The unmet need, mechanism, clinical evidence, market opportunity, and milestones did not yet connect as one story.
Scientific diagrams, clinical charts, and company slides looked like they came from different presentations.
Every document, chart, screenshot, and working slide, into one source.
Need → mechanism → evidence → market → catalysts.
One visual language across light and dark slides.
Custom science and clinical data, built for the room.
Not a gallery of disconnected slides. A deliberate progression built around how a pre-IPO opportunity is evaluated.
The unmet need and the scale of the opportunity current immunotherapy leaves behind.
Root cause, mechanism, and the lead molecule, drawn so a generalist can follow the biology.
Study design, results, durability, and safety — and the market and competition the data speaks to.
The moat, the partners, the team, and the timing that leads to a listing.
The themes are functional, not decorative. Flip the toggle and watch the same slides switch roles.
Instead of inconsistent textbook diagrams and generic medical imagery, we built custom scientific illustrations from the ground up. Each one simplifies the biology for a presentation setting while preserving the relationships the audience needs to understand.
Bloom started with strong science and valuable clinical evidence spread across multiple formats. The final company overview presentation brings everything into one connected investor journey. The science is easier to understand, the clinical signal is easier to evaluate, and the commercial opportunity arrives in the same consistent visual language.
One complete pre-IPO company overview, presentable live and readable as a leave-behind.
A coordinated dark and light system, each with a defined communication role.
Purpose-built scientific illustrations created for the company’s biology and presentation story.
From unmet need and mechanism to evidence, market opportunity, and IPO catalysts.
ChatGPT
Google AI
Claude
Perplexity
